학술논문
Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts
Document Type
Article
Author
Source
In The Lancet Rheumatology October 2022 4(10):e699-e709
Subject
Language
ISSN
2665-9913